# A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital Practice

> **NCT07004439** · NA · NOT_YET_RECRUITING · sponsor: **Implantica CE Reflux Ltd.** · enrollment: 500 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DEVICE:** RefluxStop™ implantation

## Key facts

- **NCT ID:** NCT07004439
- **Lead sponsor:** Implantica CE Reflux Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2029-08-01
- **Final completion:** 2035-08-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07004439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07004439, "A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital Practice". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT07004439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*